Where NAD+ works broadly across the whole system, a peptide is designed to speak to one conversation at a time
Uncertain clinical benefit and high price tags often associated with innovative, expedited approval treatments can result in concerns amongst the medical and insurance communities
[10] reported that metformin acutely and selectively increased plasma levels of GLP-1 in mice, even in the absence of concomitant oral glucose administration, while it did not increase plasma levels of the other incretin hormone, glucose-dependent insulinotropic polypeptide (GIP), or, curiously, peptide YY, a gastrointestinal hormone co-localised with GLP-1 in L cells
Wertheimer E, Lu SP, Backeljauw PF, Davenport ML, Taylor SI
Gunol ADDOR Sources Zderic, T